ATNM (Actinium Corp) Pangali Forward P/E

Logo grafis Actinium Pharmaceuticals, Inc. (ATNM)

The expected P/E ratio of Actinium Pharmaceuticals (ATNM) reflects the asset's value dynamics, where the 0.00 metric indicates the status of the current valuation. The business relies on the express delivery of short-lived isotopes. Strict control over the disposal of radioactive substances ensures compliance with environmental regulations. A network of local laboratories guarantees the efficiency of clinic supply, eliminating delays in drug transportation.

Rega marang bathi mangsa ngarep: Actinium Pharmaceuticals, Inc. (ATNM) kanggo 04.07.2022 - 17.11.2026

Ringkesan rincian data analitis Actinium Pharmaceuticals (ATNM)

Ringkesan analitik perusahaan:Actinium Pharma
Produk mawa merek Actinium Corp

To identify fundamental stability drivers, it is essential to analyze the forward P/E, which compares the current market value of a share with the expected earnings per share. The price action of the forward P/E multiple for Actinium Pharmaceuticals (ATNM) reflects a revision of market expectations, which is directly linked to the successful completion of FDA regulatory milestones and the expansion of the patient base in blood cancer therapy.